268 related articles for article (PubMed ID: 28389531)
61. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M
Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070
[TBL] [Abstract][Full Text] [Related]
62. Distinct cellular responses to replication stress leading to apoptosis or senescence.
Lukášová E; Řezáčová M; Bačíková A; Šebejová L; Vávrová J; Kozubek S
FEBS Open Bio; 2019 May; 9(5):870-890. PubMed ID: 30982228
[TBL] [Abstract][Full Text] [Related]
63. Exploiting bioactive natural products of marine origin: Evaluation of the meroterpenoid metachromin V as a novel potential therapeutic drug for colorectal cancer.
Lucchetti D; Luongo F; Colella F; Gurreri E; Artemi G; Desiderio C; Serra S; Giuliante F; De Maria R; Sgambato A; Vitali A; Fiori ME
Biomed Pharmacother; 2023 Jun; 162():114679. PubMed ID: 37068332
[TBL] [Abstract][Full Text] [Related]
64. CSNK1E/CTNNB1 are synthetic lethal to TP53 in colorectal cancer and are markers for prognosis.
Tiong KL; Chang KC; Yeh KT; Liu TY; Wu JH; Hsieh PH; Lin SH; Lai WY; Hsu YC; Chen JY; Chang JG; Shieh GS
Neoplasia; 2014 May; 16(5):441-50. PubMed ID: 24947187
[TBL] [Abstract][Full Text] [Related]
65. Aspirin cooperates with p300 to activate the acetylation of H3K9 and promote FasL-mediated apoptosis of cancer stem-like cells in colorectal cancer.
Chen Z; Li W; Qiu F; Huang Q; Jiang Z; Ye J; Cheng P; Low C; Guo Y; Yi X; Chen W; Yu Y; Han Y; Wu J; Jin S; Kong D; Huang J
Theranostics; 2018; 8(16):4447-4461. PubMed ID: 30214631
[TBL] [Abstract][Full Text] [Related]
66. Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition.
Diab A; Kao M; Kehrli K; Kim HY; Sidorova J; Mendez E
Mol Cancer Res; 2019 May; 17(5):1115-1128. PubMed ID: 30679201
[TBL] [Abstract][Full Text] [Related]
67. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer.
Martínez-Pérez J; Torrado C; Domínguez-Cejudo MA; Valladares-Ayerbes M
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892410
[TBL] [Abstract][Full Text] [Related]
68.
Siraj AK; Masoodi T; Bu R; Pratheeshkumar P; Al-Sanea N; Ashari LH; Abduljabbar A; Alhomoud S; Al-Dayel F; Alkuraya FS; Al-Kuraya KS
Gut; 2018 Apr; 67(4):663-671. PubMed ID: 28183795
[TBL] [Abstract][Full Text] [Related]
69. Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer.
Yin Y; Shen Q; Zhang P; Tao R; Chang W; Li R; Xie G; Liu W; Zhang L; Kapoor P; Song S; Ajani J; Mills GB; Chen J; Tao K; Peng G
Am J Cancer Res; 2017; 7(3):473-483. PubMed ID: 28401005
[TBL] [Abstract][Full Text] [Related]
70. Comparative Activity and Off-Target Effects in Cells of the CHK1 Inhibitors MK-8776, SRA737, and LY2606368.
Ditano JP; Eastman A
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):730-743. PubMed ID: 33860197
[TBL] [Abstract][Full Text] [Related]
71. PARP-1 Expression Influences Cancer Stem Cell Phenotype in Colorectal Cancer Depending on p53.
Puentes-Pardo JD; Moreno-SanJuan S; Casado J; Escudero-Feliu J; López-Pérez D; Sánchez-Uceta P; González-Novoa P; Gálvez J; Carazo Á; León J
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902215
[TBL] [Abstract][Full Text] [Related]
72. Impact of the interplay between stemness features, p53 and pol iota on replication pathway choices.
Ihle M; Biber S; Schroeder IS; Blattner C; Deniz M; Damia G; Gottifredi V; Wiesmüller L
Nucleic Acids Res; 2021 Jul; 49(13):7457-7475. PubMed ID: 34165573
[TBL] [Abstract][Full Text] [Related]
73. Nanostructured toxins for the selective destruction of drug-resistant human CXCR4
Serna N; Álamo P; Ramesh P; Vinokurova D; Sánchez-García L; Unzueta U; Gallardo A; Céspedes MV; Vázquez E; Villaverde A; Mangues R; Medema JP
J Control Release; 2020 Apr; 320():96-104. PubMed ID: 31931052
[TBL] [Abstract][Full Text] [Related]
74. Biomarker targeting of colorectal cancer stem cells.
Caparosa EM; Stem J; Snook AE; Waldman SA
Biomark Med; 2019 Aug; 13(11):891-894. PubMed ID: 31385523
[No Abstract] [Full Text] [Related]
75. The shifting paradigm of colorectal cancer treatment: a look into emerging cancer stem cell-directed therapeutics to lead the charge toward complete remission.
Kopenhaver J; Crutcher M; Waldman SA; Snook AE
Expert Opin Biol Ther; 2021 Oct; 21(10):1335-1345. PubMed ID: 33977849
[No Abstract] [Full Text] [Related]
76. Targeting breast cancer stem-like cells using chloroquine encapsulated by a triphenylphosphonium-functionalized hyperbranched polymer.
Stagni V; Kaminari A; Sideratou Z; Sakellis E; Vlahopoulos SA; Tsiourvas D
Int J Pharm; 2020 Jul; 585():119465. PubMed ID: 32497731
[TBL] [Abstract][Full Text] [Related]
77. Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress.
Marx C; Sonnemann J; Maddocks ODK; Marx-Blümel L; Beyer M; Hoelzer D; Thierbach R; Maletzki C; Linnebacher M; Heinzel T; Krämer OH
Cancer Metab; 2022 Jul; 10(1):10. PubMed ID: 35787728
[TBL] [Abstract][Full Text] [Related]
78. NSC30049 inhibits Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations.
Narayan S; Jaiswal AS; Sharma R; Nawab A; Duckworth LV; Law BK; Zajac-Kaye M; George TJ; Sharma J; Sharma AK; Hromas RA
Oncotarget; 2017 Aug; 8(34):57246-57264. PubMed ID: 28915668
[TBL] [Abstract][Full Text] [Related]
79. Identification of Novel Molecules Targeting Cancer Stem Cells.
Benoit YD
Methods Mol Biol; 2018; 1765():333-347. PubMed ID: 29589319
[TBL] [Abstract][Full Text] [Related]
80. p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis.
Solé L; Lobo-Jarne T; Álvarez-Villanueva D; Alonso-Marañón J; Guillén Y; Guix M; Sangrador I; Rozalén C; Vert A; Barbachano A; Lop J; Salido M; Bellosillo B; García-Romero R; Garrido M; González J; Martínez-Iniesta M; López-Arribillaga E; Salazar R; Montagut C; Torres F; Iglesias M; Celià-Terrassa T; Muñoz A; Villanueva A; Bigas A; Espinosa L
Nat Commun; 2022 May; 13(1):2866. PubMed ID: 35606354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
